Brief: Neovacs Progresses Towards Trial Stage For Lupus Treatment

Neovacs SA

13/04/2023 07:10

April 13 (Reuters) - Neovacs SA  ALNEV.PA :
    * NEW ADVANCES IN THE TREATMENT OF LUPUS
    * NEOVACS ANNOUNCES NEW STEP IN DEVELOPMENT OF ITS STRATEGIC
PARTNERSHIP WITH BIOSENSE GLOBAL LLC FOR TREATMENT OF LUPUS
    * AGREEMENT WOULD ALLOW RESUMPTION OF CLINICAL TRIALS IN
CHINA,
FULLY SUPPORTED BY BIOSENSE GLOBAL, AND OFFERS NEOVACS NEW
PERSPECTIVE ON VALUE OF STRATEGIC ASSET AT NO COST
    * ITS PARTNER HAS RECEIVED POSITIVE FEEDBACK, GREEN LIGHT
FROM
NMPA, THE CHINESE HEALTH AUTHORITY, FOR IND SUBMISSION
    * BIOSENSE GLOBAL HAS THEREFORE ENTERED NEW PHASE WITH THE
PREPARATION OF THE IND
    * BIOSENSE GLOBAL IS SEEKING PARTNERS TO FINANCIALLY SUPPORT
THE
NEXT STEPS IN ITS DEVELOPMENT

Source text for Eikon:  ID:nACT79318 
Further company coverage:  ALNEV.PA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00))